Related references
Note: Only part of the references are listed.Expected Value of Sample Information to Guide the Design of Group Sequential Clinical Trials
Laura Flight et al.
MEDICAL DECISION MAKING (2022)
Costs and staffing resource requirements for adaptive clinical trials: quantitative and qualitative results from the Costing Adaptive Trials project
Nina Wilson et al.
BMC MEDICINE (2021)
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey
Joanna C. Thorn et al.
VALUE IN HEALTH (2021)
Can adaptive clinical trials help to solve the productivity crisis of the pharmaceutical industry?-a scenario analysis
Joerg Mahlich et al.
HEALTH ECONOMICS REVIEW (2021)
A scoping review shows that several nonvalidated budget planning tools for randomized trials are available
Benjamin Speich et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement
Sarah P. Blagden et al.
BRITISH JOURNAL OF CANCER (2020)
How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis
Laura Flight et al.
TRIALS (2020)
Value of Information Analysis for Research Decisions-An Introduction: Report 1 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force
Elisabeth Fenwick et al.
VALUE IN HEALTH (2020)
An overview of platform trials with a checklist for clinical readers
Jay J. H. Park et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2020)
Value of Information Analytical Methods: Report 2 of the ISPOR Value of Information Analysis Emerging Good Practices Task Force
Claire Rothery et al.
VALUE IN HEALTH (2020)
Multiple Interventions for Diabetic Foot Ulcer Treatment Trial (MIDFUT): study protocol for a randomised controlled trial
Sarah Brown et al.
BMJ OPEN (2020)
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
Munyaradzi Dimairo et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs
Thomas Burnett et al.
BMC MEDICINE (2020)
A Review of Clinical Trials With an Adaptive Design and Health Economic Analysis
Laura Flight et al.
VALUE IN HEALTH (2019)
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols
Francesca Schiavone et al.
TRIALS (2019)
Changing platforms without stopping the train: experiences of data management and data management systems when adapting platform protocols by adding and closing comparisons
Dominic Hague et al.
TRIALS (2019)
When to keep it simple - adaptive designs are not always useful
James M. S. Wason et al.
BMC MEDICINE (2019)
Progression criteria in trials with an internal pilot: an audit of publicly funded randomised controlled trials
Esther Herbert et al.
TRIALS (2019)
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
Jay J. H. Park et al.
TRIALS (2019)
Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review
Colene Bentley et al.
CLINICAL TRIALS (2019)
Adaptive designs in clinical trials: why use them, and how to run and report them
Philip Pallmann et al.
BMC MEDICINE (2018)
Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list
Benjamin Speich et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Systematic review on costs and resource use of randomized clinical trials shows a lack of transparent and comprehensive data
Benjamin Speich et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2018)
Key design considerations for adaptive clinical trials: a primer for clinicians
Kristian Thorlund et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Key design considerations for adaptive clinical trials: a primer for clinicians
Kristian Thorlund et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Response-adaptive clinical trials: case studies in the medical literature
Andrew P. Grieve
PHARMACEUTICAL STATISTICS (2017)
A multi-stage drop-the-losers design for multi-arm clinical trials
James Wason et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2017)
A Bayesian decision theoretic model of sequential experimentation with delayed response
Stephen Chick et al.
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2017)
How much do clinical trials cost?
Linda Martin et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Lessons learned from recruiting socioeconomically disadvantaged smokers into a pilot randomized controlled trial to explore the role of Exercise Assisted Reduction then Stop (EARS) smoking
Tom P. Thompson et al.
TRIALS (2015)
USE OF VALUE OF INFORMATION IN UK HEALTH TECHNOLOGY ASSESSMENTS
Syed Mohiuddin et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2014)
A comparison of Bayesian adaptive randomization and multi-stage designs for multi-arm clinical trials
James M. S. Wason et al.
STATISTICS IN MEDICINE (2014)
Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
Thomas Jaki
CLINICAL TRIALS (2013)
Optimal design of multi-arm multi-stage trials
James M. S. Wason et al.
STATISTICS IN MEDICINE (2012)
Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings
Sarah C. Emerson et al.
STATISTICS IN MEDICINE (2011)
Operational challenges in adaptive design implementation
P Gallo
PHARMACEUTICAL STATISTICS (2006)
Confidentiality and trial integrity issues for adaptive designs
Paul Gallo
DRUG INFORMATION JOURNAL (2006)
Statistics Notes - Blinding in clinical trials and other studies
SJ Day et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
